Description
“清糖院内”系统是专业糖尿病管理平台，为医院糖尿病管理提供全面的解决方案。
产品主要功能：
检测任务、测量记录、报警提醒，为护士提供便捷的患者管理方案；
血糖曲线、指血记录、动态血糖，为医生提供高效的分析工具；
复测提醒、推迟提醒，通过自动化手段提升医护人员工作效率；
质量记录，解决医院设备监管难，数据溯源难等问题。
我公司作为社会企业，团队通过多年对糖尿病及慢病数据管理难的问题潜心钻研，并贯彻经济向善、商业向善的可持续发展路线，探索以IOT设备数据采集为抓手，搭建IOT和AI+赋能下的院内外慢病精准诊疗管控大数据平台，提升对糖尿病前期预测，诊疗，精准管控的闭环模式。配合智能硬件、医学AI算法辅助、远程医疗、社区康养资源覆盖实现基于糖尿病的全周期服务。致力于帮助用户养成对体征数据持续监测习惯，结合糖尿病“五驾马车”的理论模型，帮助用户建立数据队列并长期监测。帮助慢病管理的医疗技术普及和下沉，为糖尿病患者和医护人员提供全周期技术设备及服务。
Hide
Show More...
产品主要功能：
检测任务、测量记录、报警提醒，为护士提供便捷的患者管理方案；
血糖曲线、指血记录、动态血糖，为医生提供高效的分析工具；
复测提醒、推迟提醒，通过自动化手段提升医护人员工作效率；
质量记录，解决医院设备监管难，数据溯源难等问题。
我公司作为社会企业，团队通过多年对糖尿病及慢病数据管理难的问题潜心钻研，并贯彻经济向善、商业向善的可持续发展路线，探索以IOT设备数据采集为抓手，搭建IOT和AI+赋能下的院内外慢病精准诊疗管控大数据平台，提升对糖尿病前期预测，诊疗，精准管控的闭环模式。配合智能硬件、医学AI算法辅助、远程医疗、社区康养资源覆盖实现基于糖尿病的全周期服务。致力于帮助用户养成对体征数据持续监测习惯，结合糖尿病“五驾马车”的理论模型，帮助用户建立数据队列并长期监测。帮助慢病管理的医疗技术普及和下沉，为糖尿病患者和医护人员提供全周期技术设备及服务。
Screenshots
清糖院内 FAQ
-
Is 清糖院内 free?
Yes, 清糖院内 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 清糖院内 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 清糖院内 cost?
清糖院内 is free.
-
What is 清糖院内 revenue?
To get estimated revenue of 清糖院内 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in India yet.
Ratings History
清糖院内 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
清糖院内 Installs
Last 30 days
清糖院内 Revenue
Last 30 days清糖院内 Revenue and Downloads
Gain valuable insights into 清糖院内 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 北京众想智云信息技术有限公司
- Languages
- Chinese
- Recent release
- 3.1.6 (7 months ago )
- Released on
- Mar 10, 2024 (9 months ago )
- Also available in
- Pakistan , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Sri Lanka , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , India , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Denmark , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , United Arab Emirates , Dominican Republic , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 6 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.